Expression of CD28 and cytotoxic T lymphocyte antigen 4 at the maternal-fetal interface in women with unexplained pregnancy loss
Authors:
- Zhengwen MaZMZhengwen Ma
- Yan HongYHYan Hong
- Peihua LuPLPeihua Lu
- Qide LinQLQide Lin
- 6 March 2006
- journal article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 93 (2) , 123-129
Abstract
To investigate the expression of CD28 and CTLA-4, two costimulatory molecules involved in T-cell activation at the maternal-fetal interface in women with unexplained pregnancy loss. A total of 57 women, 39 with unexplained spontaneous abortion (SA) and 18 with unexplained recurrent spontaneous abortion (RSA), were enrolled in the study. A high-resolution spectratyping analysis of fluorescent bands was performed to detect CD28 and CTLA-4 expression in decidual tissues. The mean expression of CTLA-4 mRNA was significantly higher in women with SA than in controls (P<0.05). Moreover, the expression of CTLA-4 was higher in SA patients with genotype AA and phenotype A+ (AA+AG) than in controls (P<0.01). The expression of CTLA-4 was not significantly different in patients with RSA and in controls. The expression of CD28 was significantly decreased in patients with RSA (P<0.01) and SA (P<0.05) compared with controls. The mean ratios of CTLA-4/CD28 were significantly higher in patients with RSA (P<0.01) and SA (P<0.05) than in controls. This study suggests that an imbalance in CTLA-4/CD28 expression or suppressed T-cell activity at the maternal-fetal interface may confer susceptibility to unexplained pregnancy loss.Keywords
This publication has 22 references indexed in Scilit:
- The Skewed TCR‐BV Repertoire Displayed at the Maternal–Fetal Interface of Women with Unexplained Pregnancy LossAmerican Journal of Reproductive Immunology, 2005
- Association of the A/G Polymorphism at Position 49 in Exon 1 of CTLA‐4 with the Susceptibility to Unexplained Recurrent Spontaneous Abortion in the Chinese PopulationAmerican Journal of Reproductive Immunology, 2005
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemiaBlood, 2003
- CTLA-4 gene expression is influenced by promoter and exon 1 polymorphismsGenes & Immunity, 2001
- Alloimmune Causes of Recurrent Pregnancy LossSeminars in Reproductive Medicine, 2000
- Immunology at the Maternal-Fetal Interface: Lessons for T Cell Tolerance and SuppressionAnnual Review of Immunology, 2000
- T Cell Awareness of Paternal Alloantigens During PregnancyScience, 1995
- CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.Journal of Experimental Medicine, 1995
- Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity, 1994